Nutraceuticals a Food for Thought in the Treatment of Parkinson's Disease

被引:4
作者
Bansal, Keshav [1 ]
Singh, Sakshi [1 ]
Singh, Vanshita [1 ]
Bajpai, Meenakshi [1 ]
机构
[1] GLA Univ, Inst Pharmaceut Res, Mathura, India
关键词
Nutraceuticals; Parkinson's disease; oxidative stress; mitochondrial dysfunction; nutritional food; PD symptoms; CEREBRAL ISCHEMIA-REPERFUSION; ALPHA-SYNUCLEIN; GALLIC ACID; ASIATIC ACID; MOUSE MODEL; RAT MODEL; PHARMACOLOGICAL-ACTIVITIES; INDUCED NEUROTOXICITY; OXIDATIVE STRESS; ROSMARINIC ACID;
D O I
10.2174/1573401319666230515104325
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Background Brain disorders are presently one of the most serious and challenging health issues in the world. A significant portion of morbidities and fatalities worldwide are caused by these brain disorders. Parkinson's disease (PD) is a neurological condition that develops when dopaminergic neurons are lost in the substantia nigra, causing cognitive and motor impairment.Objectives Conventional treatment modalities, including dopamine replacement therapy and optimization of dopaminergic transmission approaches, don't address the pathogenic processes primary to the symptoms of PD and usually become the least essential with time. Researchers are aiming to provide effective treatment in treating PD with minimizing adverse consequences. In the past few years, a number of studies on nutraceuticals have been conducted to produce foods with fewer adverse effects and increased therapeutic effectiveness. The use of these nutraceuticals is typically risk-free and can be coupled with the patient's current common pharmacological therapy to enhance the standard of living and lessen PD symptoms.Conclusion The current review focuses on a number of important nutritional compounds and dietary changes that have been shown to be effective against a number of the pathogenic pathways involved in the onset and progression of Parkinson's disease (PD), and further lights the justification for their prospect use in the treatment and prevention of PD.
引用
收藏
页码:961 / 977
页数:17
相关论文
共 173 条
  • [1] Mechanism of the neuroprotective role of coenzyme Q10 with or without L-dopa in rotenone-induced parkinsonism
    Abdin, Amany A.
    Hamouda, Hala E.
    [J]. NEUROPHARMACOLOGY, 2008, 55 (08) : 1340 - 1346
  • [2] Long-chain polyunsaturated fatty acid sources and evaluation of their nutritional and functional properties
    Abedi, Elahe
    Sahari, Mohammad Ali
    [J]. FOOD SCIENCE & NUTRITION, 2014, 2 (05): : 443 - 463
  • [3] Free radicals and antioxidants in cardiovascular diseases
    Abrescia, Paolo
    Golino, Paolo
    [J]. EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2005, 3 (01) : 159 - 171
  • [4] Disease Prevention and Treatment Using β-Carotene: the Ultimate Provitamin A
    Anand, Raksha
    Mohan, Lalit
    Bharadvaja, Navneeta
    [J]. REVISTA BRASILEIRA DE FARMACOGNOSIA-BRAZILIAN JOURNAL OF PHARMACOGNOSY, 2022, 32 (04): : 491 - 501
  • [5] Resveratrol Derivatives as Potential Treatments for Alzheimer's and Parkinson's Disease
    Arbo, Bruno Dutra
    Andre-Miral, Corinne
    Nasre-Nasser, Raif Gregorio
    Schimith, Lucia Emanueli
    Santos, Michele Goulart
    Costa-Silva, Dennis
    Muccillo-Baisch, Ana Luiza
    Hort, Mariana Appel
    [J]. FRONTIERS IN AGING NEUROSCIENCE, 2020, 12
  • [6] Aung H H, 2007, Exp Oncol, V29, P175
  • [7] Gallic acid: a versatile antioxidant with promising therapeutic and industrial applications
    Badhani, Bharti
    Sharma, Neha
    Kakkar, Rita
    [J]. RSC ADVANCES, 2015, 5 (35) : 27540 - 27557
  • [8] Gallic acid: Pharmacological activities and molecular mechanisms involved in inflammation-related diseases
    Bai, Jinrong
    Zhang, Yunsen
    Tang, Ce
    Hou, Ya
    Ai, Xiaopeng
    Chen, Xiaorui
    Zhang, Yi
    Wang, Xiaobo
    Meng, Xianli
    [J]. BIOMEDICINE & PHARMACOTHERAPY, 2021, 133
  • [9] Neuroprotective Potential of Hesperidin as Therapeutic Agent in the Treatment of Brain Disorders: Preclinical Evidence-based Review
    Bansal, Keshav
    Singh, Vanshita
    Singh, Sakshi
    Mishra, Samiksha
    [J]. CURRENT MOLECULAR MEDICINE, 2024, 24 (03) : 316 - 326
  • [10] A Randomized Clinical Trial of High-Dosage Coenzyme Q10 in Early Parkinson Disease No Evidence of Benefit
    Beal, M. Flint
    Oakes, David
    Shoulson, Ira
    Henchcliffe, Claire
    Galpern, Wendy R.
    Haas, Richard
    Juncos, Jorge L.
    Nutt, John G.
    Voss, Tiffini Smith
    Ravina, Bernard
    Shults, Clifford M.
    Helles, Karen
    Snively, Victoria
    Lew, Mark F.
    Griebner, Brian
    Watts, Arthur
    Gao, Shan
    Pourcher, Emmanuelle
    Bond, Louisette
    Kompoliti, Katie
    Agarwal, Pinky
    Sia, Cherissa
    Jog, Mandar
    Cole, Linda
    Sultana, Munira
    Kurlan, Roger
    Richard, Irene
    Deeley, Cheryl
    Waters, Cheryl H.
    Figueroa, Angel
    Arkun, Ani
    Brodsky, Matthew
    Ondo, William G.
    Hunter, Christine B.
    Jimenez-Shahed, Joohi
    Palao, Alicia
    Miyasaki, Janis M.
    Julie, S. O.
    Tetrud, James
    Reys, Liza
    Smith, Katharine
    Singer, Carlos
    Blenke, Anita
    Russell, David S.
    Cotto, Candace
    Friedman, Joseph H.
    Lannon, Margaret
    Zhang, Lin
    Drasby, Edward
    Kumar, Rajeev
    [J]. JAMA NEUROLOGY, 2014, 71 (05) : 543 - 552